Cargando…

Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer’s disease

Imbalance between amyloid-beta (Aβ) peptide synthesis and clearance results in Aβ deregulation. Failure to clear these peptides appears to cause the development of Alzheimer’s disease (AD). In recent years, microRNAs have become established key regulators of biological processes that relate among ot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madadi, Soheil, Schwarzenbach, Heidi, Saidijam, Massoud, Mahjub, Reza, Soleimani, Meysam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852943/ https://www.ncbi.nlm.nih.gov/pubmed/31749959 http://dx.doi.org/10.1186/s13578-019-0354-3

Ejemplares similares

Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and In Vitro Characterization
por: Darabi, Farnosh, et al.
Publicado: (2022)

Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
por: Kim, Dong Eun, et al.
Publicado: (2020)

Simultaneous Analysis of Multidrug Resistance 1(MDR1) C3435T, G2677T/A, and C1236T Genotypes in Hamadan City Population, West of Iran
por: Saidijam, Massoud, et al.
Publicado: (2015)

Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer’s Disease
por: Yoon, Sang-Sun, et al.
Publicado: (2012)

Evidence for impaired amyloid β clearance in Alzheimer's disease
por: Wildsmith, Kristin R, et al.
Publicado: (2013)

A Novel Hyperthermostable Recombinant Protein Nanocage
por: Ahmadyousefi, Yaghoub, et al.
Publicado: (2022)

Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β
por: Schonrock, Nicole, et al.
Publicado: (2010)

microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment
por: Kazemi, Sima, et al.
Publicado: (2021)

Predicting the survival time for diffuse large B-cell lymphoma using microarray data
por: Khoshhali, Mehri, et al.
Publicado: (2012)

Editorial: Clearance Pathways for Amyloid-β. Significance for Alzheimer's Disease and Its Therapy
por: Carare, Roxana O.
Publicado: (2017)

Designing a novel ELISA method based on CagA, NapA recombinant antigens to increase sensitivity and specificity of Helicobacter pylori whole cell antigen detection
por: Kamarehei, Farideh, et al.
Publicado: (2018)

Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
por: Kline, Adam
Publicado: (2012)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

Interplay between LncRNAs and microRNAs in Breast Cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2023)

MicroRNA-183 Family in Inner Ear: Hair Cell Development and Deafness
por: Mahmoodian sani, Mohammad Reza, et al.
Publicado: (2016)

Evaluation of MicroRNA-99a and MicroRNA-205 Expression Levels in Bladder Cancer
por: Ganji, Sajjad Mohammad, et al.
Publicado: (2017)

Angioregulatory microRNAs in Colorectal Cancer
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2019)

Competing Risks Data Analysis with High-dimensional Covariates: An Application in Bladder Cancer
por: Tapak, Leili, et al.
Publicado: (2015)

Predicting the Survival Time for Bladder Cancer Using an Additive Hazards Model in Microarray Data
por: TAPAK, Leili, et al.
Publicado: (2016)

Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer
por: Bastaminejad, Saiyad, et al.
Publicado: (2017)

Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer’s disease
por: Xiang, Yang, et al.
Publicado: (2015)

Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
por: Thal, Dietmar R.
Publicado: (2015)

MicroRNA Shuttle from Cell-To-Cell by Exosomes and Its Impact in Cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2019)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2021)

Computational Study of Natural Compounds for the Clearance of Amyloid-Βeta: A Potential Therapeutic Management Strategy for Alzheimer’s Disease
por: Ahmad, Syed Sayeed, et al.
Publicado: (2019)

Reduced CSF Water Influx in Alzheimer’s Disease Supporting the β-Amyloid Clearance Hypothesis
por: Suzuki, Yuji, et al.
Publicado: (2015)

URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease
por: Kiyota, Tomomi, et al.
Publicado: (2018)

Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies
por: Yang, Hai, et al.
Publicado: (2022)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease
por: Kanekiyo, Takahisa, et al.
Publicado: (2014)

Rapid in vivo measurement of β-amyloid reveals biphasic clearance kinetics in an Alzheimer’s mouse model
por: Yuede, Carla M., et al.
Publicado: (2016)

Sodium rutin ameliorates Alzheimer’s disease–like pathology by enhancing microglial amyloid-β clearance
por: Pan, Rui-Yuan, et al.
Publicado: (2019)

Association between risk of brucellosis and genetic variations in MicroRNA-146a
por: Kazemi, Sima, et al.
Publicado: (2021)

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2022)

Ubiquitin binds the amyloid β peptide and interferes with its clearance pathways
por: Bellia, F., et al.
Publicado: (2019)

Circulating microRNAs: promising breast cancer biomarkers - authors' response
por: Roth, Carina, et al.
Publicado: (2011)

Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer’s disease
por: Zhang, Xiao, et al.
Publicado: (2021)

Nogo receptor impairs the clearance of fibril amyloid‐β by microglia and accelerates Alzheimer’s‐like disease progression
por: Wang, Jianing, et al.
Publicado: (2021)

The Amyloid-β Pathway in Alzheimer’s Disease
por: Hampel, Harald, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qvojv1mac4p1r6nta5b4g90hml